Multifocal ERG defects associated with insufficient long-term glycemic control in adolescents with type 1 diabetes

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 10, 2010, Pages 5297-5303

  Lakhani, Ekta ^a   Wright, Tom ^a   Abdolell, Mohamed ^b,c   Westall, Carol ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ELECTRORETINOGRAM; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MULTIFOCAL ELECTRORETINOGRAM; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; BLOOD; CONTRAST SENSITIVITY; ELECTRORETINOGRAPHY; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA; RETINA DISEASE; VISUAL ACUITY;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CONTRAST SENSITIVITY; DIABETES MELLITUS, TYPE 1; ELECTRORETINOGRAPHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; RETINA; RETINAL DISEASES; VISUAL ACUITY; YOUNG ADULT;

EID: 77958138779     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5200     Document Type: Article

References (74)

1. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520-526.
2. Lecaire T, Palta M, Zhang H, Allen C, Klein R, D'Alessio D. Lowerthan- expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: The Wisconsin Diabetes Registry Study. Am J Epidemiol. 2006; 164:143-150.
3. International Diabetes Federation. United for Diabetes Campaign: Key Messages. Brussels, Belgium; 2007.
4. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:786-806.
5. Juen S, Kieselbach GF. Electrophysiological changes in juvenile diabetics without retinopathy. Arch Ophthalmol. 1990;108:372-375.
6. Bresnick GH, Palta M. Oscillatory potential amplitudes: relation to severity of diabetic retinopathy. Arch Ophthalmol. 1987;105:929-933.
7. Bresnick GH, Palta M. Predicting progression to severe proliferative diabetic retinopathy. Arch Ophthalmol. 1987;105:810-814.
8. Simonsen SE. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol (Copenh). 1980;58:865-878.
9. Bearse MA Jr, Han Y, Schneck ME, Barez S, Jacobsen C, Adams AJ. Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45: 3259-3265.
10. Bearse MA Jr, Han Y, Schneck ME, Adams AJ. Retinal function in normal and diabetic eyes mapped with the slow flash multifocal electroretinogram. Invest Ophthalmol Vis Sci. 2004;45:296-304.
11. Kurtenbach A, Langrova H, Zrenner E. Multifocal oscillatory potentials in type 1 diabetes without retinopathy. Invest Ophthalmol Vis Sci. 2000;41:3234-3241.
12. Fortune B, Schneck ME, Adams AJ. Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1999;40:2638-2651.
13. Bearse MA Jr, Adams AJ, Han Y, et al. A multifocal electroretinogram model predicting the development of diabetic retinopathy. Prog Retin Eye Res. 2006;25:425-448.
14. Han Y, Bearse MA Jr, Schneck ME, Barez S, Jacobsen CH, Adams AJ. Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45:948-954.
15. Han Y, Schneck ME, Bearse MA Jr, et al. Formulation and evaluation of a predictive model to identify the sites of future diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45:4106-4112.
16. Ng JS, Bearse MA Jr, Schneck ME, Barez S, Adams AJ. Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Invest Ophthalmol Vis Sci. 2008;49:1622-1628.
17. Hood DC. Assessing retinal function with the multifocal technique. Prog Retin Eye Res. 2000;19:607-646.
18. Palmowski AM, Sutter EE, Bearse MA Jr, Fung W. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram. Invest Ophthalmol Vis Sci. 1997;38:2586-2596.
19. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-986.
20. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr. 1994;125:177-188.
21. Daneman D, Wolfson DH, Becker DJ, Drash AL. Factors affecting glycosylated hemoglobin values in children with insulin-dependent diabetes. J Pediatr. 1981;99:847-853.
22. Mortensen HB, Villumsen J, Volund A, Petersen KE, Nerup J. Relationship between insulin injection regimen and metabolic control in young Danish type 1 diabetic patients. The Danish Study Group of Diabetes in Childhood. Diabet Med. 1992;9:834-839.
23. Townsend RR, Kapoor SC. The effect of intensive treatment of diabetes mellitus. N Engl J Med. 1994;330:641, author reply, 642.
24. Klemp K, Larsen M, Sander B, Vaag A, Brockhoff PB, Lund- Andersen H. Effect of short-term hyperglycemia on multifocal electroretinogram in diabetic patients without retinopathy. Invest Ophthalmol Vis Sci. 2004;45:3812-3819.
25. Klemp K, Sander B, Brockhoff PB, Vaag A, Lund-Andersen H, Larsen M. The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping. Invest Ophthalmol Vis Sci. 2005;46:2620-2626.
26. Mollon JD Reffin JP. Manual for the Mollon-Reffin Minimalist Test. Version 0.7.Cambridge, UK: Oxford University Press; 1994.
27. Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118:69-77.
28. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 2002;16:242-260.
29. Frank RN. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. Am J Ophthalmol. 2002;133: 693-698.
30. Hood DC. Electrophysiologic imaging of retinal and optic nerve damage: the multifocal technique. Ophthalmol Clin North Am. 2004;17:69-88.
31. Kondo M, Miyake Y, Horiguchi M, Suzuki S, Tanikawa A. Clinical evaluation of multifocal electroretinogram. Invest Ophthalmol Vis Sci. 1995;36:2146-2150.
32. Sutter E. Imaging visual function with the multifocal m-sequence technique. Vision Res. 2001;41:1241-1255.
33. Sutter E, Tran D. The field topography of ERG components in man. I. The photopic luminance response. Vision Res. 1992;32:433-446.
34. Keating D, Parks S, Smith D, Evans A. The multifocal ERG: unmasked by selective cross-correlation. Vision Res. 2002;42:2959-2968.
35. Bearse MA Jr, Shimada Y, Sutter EE. Distribution of oscillatory components in the central retina. Doc Ophthalmol. 2000;100: 185-205.
36. Fortune B, Wang L, Bui BV, Cull G, Dong J, Cioffi GA. Local ganglion cell contributions to the macaque electroretinogram revealed by experimental nerve fiber layer bundle defect. Invest Ophthalmol Vis Sci. 2003;44:4567-4579.
37. Hood DC, Seiple W, Holopigian K, Greenstein V. A comparison of the components of the multifocal and full-field ERGs. Vis Neurosci. 1997;14:533-544.
38. Rangaswamy NV, Hood DC, Frishman LJ. Regional variations in local contributions to the primate photopic flash ERG: revealed using the slow-sequence mfERG. Invest Ophthalmol Vis Sci. 2003; 44:3233-3247.
39. Wu S, Sutter EE. A topographic study of oscillatory potentials in man. Vis Neurosci. 1995;12:1013-1025.
40. Hood DC, Li, J. A technique for measuring individual multifocal ERG recordings. In: Yager D, ed. Trends in Optics and Photonics. Washington DC: Optical Society of America; 1997:280-283.
41. Lindsey JK, Jones B. Choosing among generalized linear models applied to medical data. Stat Med. 1998;17:59-68.
42. Dunteman GH, Ho M-H.R. An Introduction to Generalized Linear Models. San Francisco: Sage Publications; 2006:72.
43. Gardner W, Mulvey EP, Shaw EC. Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. Psychol Bull. 1995;118:392-404.
44. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2008.
45. Sauerbrei W. The use of resampling methods to simplify regression models in medical statistics. Appl Stat. 1999;48:313-329.
46. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, eds. Second International Symposium on Inference Theory. Budapest: Akademiai Kiado; 1973:267-281.
47. Bronson-Castain K, Bearse MA, Neuville J, et al. Early indication of focal retinal neuropathy and retinal thinning in adolescents with type 1 and type 2 diabetes. Diabetes. 2008;57:A224.
48. Bronson-Castain K. Type 1 and type 2 diabetes in adulthood and adolescence: focal retinal function, structure and vascular health. Vision Science. Berkeley: University of California Berkeley; 2008: 250. Thesis.
49. Bresnick GH, Korth K, Groo A, Palta M. Electroretinographic oscillatory potentials predict progression of diabetic retinopathy: preliminary report. Arch Ophthalmol. 1984;102:1307-1311.
50. Hancock HA, Kraft TW. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci. 2004;45: 1002-1008.
51. Shirao Y, Kawasaki K. Electrical responses from diabetic retina. Prog Retin Eye Res. 1998;17:59-76.
52. Frost-Larsen K, Christiansen JS, Parving HH. The effect of strict short-term metabolic control on retinal nervous system abnormalities in newly diagnosed type 1 (insulin-dependent) diabetic patients. Diabetologia. 1983;24:207-209.
53. Lovasik JV, Kergoat H. Electroretinographic results and ocular vascular perfusion in type 1 diabetes. Invest Ophthalmol Vis Sci. 1993;34:1731-1743.
54. Barber AJ, Antonetti DA, Kern TS, et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46:2210-2218.
55. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest. 1998;102:783-791.
56. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci. 2004;45:3330-3336.
57. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102:527-532.
58. Burger W, Hovener G, Dusterhus R, Hartmann R, Weber B. Prevalence and development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus: a longitudinal study. Diabetologia. 1986;29:17-22.
59. Frank RN, Hoffman WH, Podgor MJ, et al. Retinopathy in juvenileonset type I diabetes of short duration. Diabetes. 1982;31:874-882.
60. Jackson RL, Ide CH, Guthrie RA, James RD. Retinopathy in adolescents and young adults with onset of insulin-dependent diabetes in childhood. Ophthalmology. 1982;89:7-13.
61. Klein BE, Moss SE, Klein R. Is menarche associated with diabetic retinopathy? Diabetes Care. 1990;13:1034-1038.
62. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Retinopathy in young-onset diabetic patients. Diabetes Care. 1985;8:311-315.
63. Knowles HC Jr, Guest GM, Lampe J, Kessler M, Skillman TG. The course of juvenile diabetes treated with unmeasured diet. Diabetes. 1965;14:239-273.
64. Malone JI, Grizzard S, Espinoza LR, Achenbach KE, Van Cader TC. Risk factors for diabetic retinopathy in youth. Pediatrics. 1984;73:756-761.
65. Fortune B, Johnson CA. Decline of photopic multifocal electroretinogram responses with age is due primarily to preretinal optical factors. J Opt Soc Am A Opt Image Sci Vis. 2002;19:173-184.
66. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
67. Ceriello A. The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med. 1998;15:188-193.
68. Ceriello A. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia. 2003; 46(suppl 1):M9-M16.
69. Gallagher A, Home PD. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes. Diabetes Res Clin Pract. 2005;67:196-203.
70. Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care. 2006;29:1486-1490.
71. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103-117.
72. Service FJ, O'Brien PC. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia. 2001;44:1215-1220.
73. Shiraiwa T, Kaneto H, Miyatsuka T, et al. Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients. Biochem Biophys Res Commun. 2005;336:339-345.
74. Weber C, Schnell O. The assessment of glycemic variability and its impact on diabetes-related complications: an overview. Diabetes Technol Ther. 2009;11:623-633.